EPINEPHRINE INJECTION, USP

PRESERVATIVE FREE

SULFITE FREE

Rx Only

Each mL contains Epinephrine 1 mg (as the hydrochloride), Sodium Chloride 9 mg, and Water for Injection q.s. Contains no Sulfites. pH adjusted with Hydrochloric Acid and/or Sodium Hydroxide.

Epinephrine is the active principle of the adrenal medulla. Chemically described as (-)-3,4-Dihydroxy-α-[(methylamino)methyl] benzyl alcohol.

Epinephrine is a sympathomimetic drug. It activates an adrenergic receptive mechanism on effector cells and imitates all actions of the sympathetic nervous system except those on the arteries of the face and sweat glands. Epinephrine acts on both alpha and beta receptors and is the most potent alpha receptor activator.

In general, the most common uses of epinephrine are to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity reactions to drugs and other allergens, and to prolong the action of infiltration anesthetics. Its cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes, but it is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock.

Epinephrine is used as a hemostatic agent. It is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. Epinephrine injection can be utilized to prolong the action of intraspinal and local anesthetics (see CONTRAINDICATIONS).

Epinephrine is contraindicated in narrow-angle (congestive) glaucoma, shock, during general anesthesia with halogenated hydrocarbons or cyclopropane and in individuals with organic brain damage. Epinephrine is also contraindicated with local anesthesia of certain areas, e.g., fingers, toes, because of the danger of vasoconstriction producing sloughing of tissue; in labor because it may delay the second stage; in cardiac dilatation and coronary insufficiency.

Administer with caution to elderly people; to those with cardiovascular disease, hypertension, diabetes, or hyperthyroidism; in psychoneurotic individuals; and in pregnancy.

Patients with long-standing bronchial asthma and emphysema who have developed degenerative heart disease should be administered the drug with extreme caution.

Overdosage or inadvertent intravenous injection of epinephrine may cause cerebrovascular hemorrhage resulting from the sharp rise in blood pressure.

Fatalities may also result from pulmonary edema because of the peripheral constriction and cardiac stimulation produced. Rapidly acting vasodilators such as nitrites, or alpha-blocking agents may counteract the marked pressor effects of epinephrine.

Epinephrine Injection should be protected from exposure to light. Do not remove ampules from carton until ready to use. The solution should not be used if its color is pinkish or darker than slightly yellow or if it contains a precipitate.

Epinephrine is readily destroyed by alkalies and oxidizing agents. In the latter category are oxygen, chlorine, bromine, iodine, permanganates, chromates, nitrites, and salts of easily reducible metals, especially iron.

Transient and minor side effects of anxiety, headache, fear, and palpitations often occur with therapeutic doses, especially in hyperthyroid individuals. Repeated local injections can result in necrosis at sites of injection from vascular constriction. “Epinephrine-fastness” can occur with prolonged use.

Intramuscularly or subcutaneously — 0.2 to 1 mL. Start with a small dose and increase if required.

Note: The subcutaneous is the preferred route of administration. If given intramuscularly, injection into the buttocks should be avoided.

For bronchial asthma and certain allergic manifestations, e.g., angioedema, urticaria, serum sickness, anaphylactic shock, use epinephrine subcutaneously. For bronchial asthma in pediatric patients, administer 0.01 mL/kg or 0.3 mL/m² to a maximum of 0.5 mL subcutaneously, repeated every four hours if required.

Sterile solution containing Epinephrine 1 mg (as the hydrochloride) in each 1 mL ampule. Supplied in a box of 25 Ampules.

NDC 0517-1071-25

AMERICAN
REGENT, INC.
SHIRLEY, NY 11967

IN1071
Rev. 01/09

PRINCIPAL DISPLAY PANEL – 1 mL Carton

EPINEPHRINE
INJECTION, USP
1:1000 (1 mg/mL)

NDC 0517-1071-25

25 x 1 mL AMPULES

CONTAINS NO SULFITES

PRESERVATIVE FREE

Rx Only

FOR SC AND IM USE.  FOR IV AND IC USE AFTER DILUTION.

Each mL contains: Epinephrine 1 mg (as the Hydrochloride), Sodium Chloride 9 mg, Water for Injection q.s.  pH adjusted with Hydrochloric Acid and/or Sodium Hydroxide.

WARNING: DO NOT USE IF DISCOLORED OR PRECIPITATED.  PROTECT FROM LIGHT. Store below 23°C (73°F). Do not freeze.

Directions for Use: See Package Insert.

AMERICAN
REGENT, INC.
SHIRLEY, NY 11967

Rev. 5/05

68b1bf4a-figure-01